We are live on ! Find out more
TC

Tavio Capital Portfolio holdings

AUM $75.4M
1-Year Est. Return 27.99%
This Fund
S&P 500
This Quarter Est. Return
-6.89%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
10 Year Est. Return
AUM
$69.3M
AUM Growth
-$202M
Cap. Flow
-$187M
Cap. Flow %
-269.85%
Top 10 Hldgs %
100%
Holding
12
New
Increased
Reduced
6
Closed
6

Top Buys

No buys this quarter

Top Sells

1
LH icon
Labcorp
LH
+$29.9M
2
ZBH icon
Zimmer Biomet
ZBH
+$29.5M
3
HCA icon
HCA Healthcare
HCA
+$28M
4
HUM icon
Humana
HUM
+$25M
5
CNC icon
Centene
CNC
+$16.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
1
Molina Healthcare
MOH
$11.7B
$20.5M 29.61%
146,862
-43,927
-23% -$5.88M
MCK icon
2
McKesson
MCK
$98.5B
$16M 23.06%
118,127
-25,543
-18% -$3.74M
CI icon
3
Cigna
CI
$74.5B
$12.5M 18.01%
70,438
-84,888
-55% -$16.5M
CNC icon
4
Centene
CNC
$32.8B
$12.2M 17.6%
205,212
-277,964
-58% -$16.9M
ZBH icon
5
Zimmer Biomet
ZBH
$17.6B
$7.3M 10.54%
74,408
-225,313
-75% -$29.5M
HCA icon
6
HCA Healthcare
HCA
$82.3B
$820K 1.18%
9,125
-216,585
-96% -$28M
BAX icon
7
Baxter International
BAX
$11.7B
-121,278
Closed -$10.1M
BSX icon
8
Boston Scientific
BSX
$65.4B
-164,433
Closed -$7.44M
HUM icon
9
Humana
HUM
$48B
-68,288
Closed -$25M
LH icon
10
Labcorp
LH
$23.2B
-205,682
Closed -$29.9M
PDCO
11
DELISTED
Patterson Companies, Inc.
PDCO
-257,289
Closed -$5.27M
PRAH
12
DELISTED
PRA Health Sciences, Inc.
PRAH
-78,141
Closed -$8.69M

Similar funds

Tavio Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Tavio Capital held 12 positions worth $69.3M, down 74% from $271M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tavio Capital withdrew a net $187M in Q1 2020, closing 6 positions and reducing 6 holdings. Its most notable exit was Labcorp, an estimated $29.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier.

  • Tavio Capital's biggest Q1 2020 reduction was Zimmer Biomet, cutting an estimated $29.5M.
  • Tavio Capital fully exited Labcorp in Q1 2020, selling an estimated $29.9M.
  • Tavio Capital's ten largest holdings make up 100% of its $69.3M portfolio in Q1 2020.
  • Tavio Capital opened 0 new positions and closed 6 in Q1 2020.
  • Tavio Capital's portfolio value fell 74% quarter-over-quarter to $69.3M.

Based on Tavio Capital's 13F filing for Q1 2020, filed 14 May 2020.